Lung cancer

• Health & Medicine

Half a million fewer deaths from lung cancer in 40 years

Lung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the rate had stayed the same Lung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the rate had stayed the same

1 February 2019

• Science & Technology
• Health & Medicine

Lung cancer screening part 2: research into detection technology could lead to better tests

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening. Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

6 December 2018

• Health & Medicine

Lung cancer screening part 1: the benefits and harms according to clinical trials

Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms. Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.

4 December 2018

• Science & Technology

Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology

This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments. This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.

30 November 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with lung cancer

Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England. Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England.

22 November 2018

• Health & Medicine

Mirati Therapeutics joins Cancer Research UK’s Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme. Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.

20 November 2018

• Health & Medicine

Screening scans 'could cut lung cancer deaths’

Introducing lung screening for people at high risk of lung cancer could reduce deaths from the disease, according to new unpublished research. Introducing lung screening for people at high risk of lung cancer could reduce deaths from the disease, according to new unpublished research.

26 September 2018

• Science & Technology

Scientists discover first step towards finding a new, targeted lung cancer treatment

Scientists have identified a key molecular player in a subtype of lung cancer, which could lead to a new way to tackle the disease. Scientists have identified a key molecular player in a subtype of lung cancer, which could lead to a new way to tackle the disease.

21 August 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018